Diagnosing the Treatments: Issues in Post-Patent Pharmaceutical Markets
Opening Remarks from the Federal Trade Commission’s Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics
Washington, DC
Date
By
Maureen K. Ohlhausen, Former Commissioner